International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care

---

Atıf İçin Kopyala

Holle L. M., Bilse T., Alabelewe R. M., Kintzel P. E., Kandemir E. A., Tan C. J., ...Daha Fazla

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, cilt.27, sa.4, ss.785-801, 2021 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 27 Sayı: 4
• Basım Tarihi: 2021
• Doi Numarası: 10.1177/10781552211017199
• Dergi Adı: JOURNAL OF ONCOLOGY PHARMACY PRACTICE
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
• Sayfa Sayıları: ss.785-801
• Anahtar Kelimeler: Oncology pharmacy, technician, patient care, practice management, research, DRUG-INTERACTIONS, ORAL CHEMOTHERAPY, CLINICAL PHARMACISTS, COST AVOIDANCE, IMPACT, MANAGEMENT, SAFETY, INTERVENTIONS, THERAPY, PREVALENCE
• Hacettepe Üniversitesi Adresli: Evet

Özet

The Oncology Pharmacy Team (OPT), consisting of specialty-trained pharmacists and/or pharmacy technicians, is an integral component of the multidisciplinary healthcare team (MHT) involved with all aspects of cancer patient care. The OPT fosters quality patient care, safety, and local regulatory compliance. The International Society of Oncology Pharmacy Practitioners (ISOPP) developed this position statement to provide guidance on five key areas: 1) oncology pharmacy practice as a pharmacy specialty; 2) contributions to patient care; 3) oncology pharmacy practice management; 4) education and training; and 5) contributions to oncology research and quality initiatives to involve the OPT. This position statement advocates that: 1) the OPT be fully incorporated into the MHT to optimize patient care; 2) educational and healthcare institutions develop programs to continually educate OPT members; and 3) regulatory authorities develop certification programs to recognize the unique contributions of the OPT in cancer patient care.